analiza aiqbench

High Q Technologies and Creative Biostructure are partnering to lower the barrier to entry for quantum-enabled EPR spectroscopy, specifically targeting the study of intrinsically disordered proteins in drug discovery. This collaboration aims to complement existing structural biology methods like cryo-EM and NMR by providing accessible workflow support for measuring long-range molecular distances and dynamic conformational changes. The initiative represents a practical step toward integrating quantum sensor technology into mainstream pharmaceutical research pipelines.